{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:59:31Z","timestamp":1780484371513,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:00:00Z","timestamp":1731456000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K15299"],"award-info":[{"award-number":["22K15299"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jphs.2024.11.002","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T08:35:01Z","timestamp":1731573301000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Different sensitivities of porcine coronary arteries and veins to BAY 60\u20132770, a soluble guanylate cyclase activator"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9282-0828","authenticated-orcid":false,"given":"Masashi","family":"Tawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Ohkita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2024.11.002_bib1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1111\/bph.12980","article-title":"Extending the translational potential of targeting NO\/cGMP-regulated pathways in the CVS","volume":"172","author":"Papapetropoulos","year":"2015","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib2","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1161\/CIRCRESAHA.117.303776","article-title":"Contemporary approaches to modulating the nitric oxide-cGMP pathway in cardiovascular disease","volume":"120","author":"Kraehling","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2024.11.002_bib3","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1517\/14656566.2015.1052742","article-title":"Use of nitrates in ischemic heart disease","volume":"16","author":"Giuseppe","year":"2015","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.jphs.2024.11.002_bib4","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s10557-016-6668-z","article-title":"Vasodilator therapy: nitrates and nicorandil","volume":"30","author":"Tarkin","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jphs.2024.11.002_bib5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1476-5381.1983.tb10012.x","article-title":"Actions of isosorbide dinitrate on smooth muscle cells of rabbit vascular tissues","volume":"79","author":"Ishikawa","year":"1983","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0014-2999(85)90674-0","article-title":"Isosorbide 5-mononitrate effects on isolated rabbit aorta and vena cava: relationship between cyclic GMP and relaxation of vascular smooth muscle","volume":"118","author":"Matsuoka","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib7","first-page":"226","article-title":"Different sensitivities of arteries and veins to glyceryltrinitrate-induced relaxation and tolerance: an \u201cin vitro\u201d study on isolated vessels from rabbits","volume":"285","author":"R\u00f6sen","year":"1987","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.jphs.2024.11.002_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1476-5381.1990.tb14657.x","article-title":"Effects of basal and acetylcholine-induced release of endothelium-derived relaxing factor on contraction to alpha-adrenoceptor agonists in a rabbit artery and corresponding veins","volume":"99","author":"McGrath","year":"1990","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0014-2999(98)00406-3","article-title":"Vasorelaxant effect of olprinone, an inhibitor of phosphodiesterase 3, on mesenteric small artery and vein of rabbits","volume":"353","author":"Fujimoto","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib10","first-page":"556","article-title":"Cilostazol-induced relaxation of calf cardiac vein and coronary artery during cooling","volume":"114","author":"Nurullahoglu-Atalik","year":"2013","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.jphs.2024.11.002_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/mol.53.3.547","article-title":"Nitric oxide inhibits vascular bioactivation of glyceryl trinitrate: a novel mechanism to explain preferential venodilation of organic nitrates","volume":"53","author":"Kojda","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/bph.15698","article-title":"Soluble GC stimulators and activators: past, present and future","author":"Sandner","year":"2024","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib13","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00210-023-02484-8","article-title":"The 10th International Conference on cGMP 2022: recent trends in cGMP research and development-meeting report","volume":"396","author":"Friebe","year":"2023","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib14","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1038\/s41467-021-25617-0","article-title":"Activation mechanism of human soluble guanylate cyclase by stimulators and activators","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jphs.2024.11.002_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2022.107023","article-title":"Factors influencing the soluble guanylate cyclase heme redox state in blood vessels","volume":"145","author":"Tawa","year":"2022","journal-title":"Vasc Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/CIRCULATIONAHA.109.870774","article-title":"Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury","volume":"120","author":"Korkmaz","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2024.11.002_bib17","doi-asserted-by":"crossref","first-page":"H1347","DOI":"10.1152\/ajpheart.00544.2011","article-title":"Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia\/reperfusion injury: role of hydrogen sulfide","volume":"302","author":"Salloum","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jphs.2024.11.002_bib18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/cvr\/cvt257","article-title":"NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size","volume":"101","author":"Bice","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jphs.2024.11.002_bib19","article-title":"Cardioprotective effects of PKG activation by soluble GC activator, BAY 60-2770, in ischemia-reperfusion-injured rat hearts","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jphs.2024.11.002_bib20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/cvr\/cvy039","article-title":"Cardioprotection by ischemic postconditioning and cyclic guanosine monophosphate-elevating agents involves cardiomyocyte nitric oxide-sensitive guanylyl cyclase","volume":"114","author":"Frankenreiter","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jphs.2024.11.002_bib21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jacbts.2021.05.004","article-title":"Implications of iron deficiency in STEMI patients and in a murine model of myocardial infarction","volume":"6","author":"Inserte","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jphs.2024.11.002_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.atherosclerosis.2011.06.042","article-title":"Measuring oxidative burden and predicting pharmacological response in coronary artery disease patients with a novel direct activator of haem-free\/oxidised sGC","volume":"218","author":"Ahrens","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jphs.2024.11.002_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.838","article-title":"Alteration of the soluble guanylate cyclase system in coronary arteries of high cholesterol diet-fed rabbits","volume":"9","author":"Tawa","year":"2021","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.jphs.2024.11.002_bib24","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.3390\/ijms24119273","article-title":"Effects of soluble guanylate cyclase stimulators and activators on anti-aggregatory signalling in patients with coronary artery spasm","volume":"24","author":"Muminovic","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphs.2024.11.002_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1124\/jpet.123.001918","article-title":"Efficacy of BAY 60-2770, a soluble guanylate cyclase activator, for coronary spasm in animal models","volume":"390","author":"Tawa","year":"2024","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.jphs.2024.11.002_bib26","doi-asserted-by":"crossref","first-page":"R1073","DOI":"10.1152\/ajpregu.00101.2015","article-title":"The vasodilatory effect of sulfur dioxide via SGC\/cGMP\/PKG pathway in association with sulfhydryl-dependent dimerization","volume":"310","author":"Yao","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.jphs.2024.11.002_bib27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00005344-200406000-00014","article-title":"Different role of nitric oxide and endothelium-derived hyperpolarizing factor in endothelium-dependent hyperpolarization and relaxation in porcine coronary arterial and venous system","volume":"43","author":"Zhang","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66639-w","article-title":"Non-canonical chemical feedback self-limits nitric oxide-cyclic GMP signaling in health and disease","volume":"10","author":"Dao","year":"2020","journal-title":"Sci Rep"},{"issue":"Suppl 11","key":"10.1016\/j.jphs.2024.11.002_bib29","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1097\/00005344-198914110-00016","article-title":"Mechanism underlying the inhibitory interaction between the nitrovasodilator SIN-1 and the endothelium","volume":"14","author":"Flavahan","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1476-5381.1994.tb13110.x","article-title":"Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery","volume":"112","author":"Kilpatrick","year":"1994","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib31","doi-asserted-by":"crossref","first-page":"H2798","DOI":"10.1152\/ajpheart.00899.2006","article-title":"Chronic nitric oxide synthase inhibition blunts endothelium-dependent function of conduit coronary arteries, not arterioles","volume":"292","author":"Ingram","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.jphs.2024.11.002_bib32","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1073\/pnas.88.6.2166","article-title":"Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo","volume":"88","author":"Moncada","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jphs.2024.11.002_bib33","series-title":"The Endothelium: Part 1: Multiple Functions of the Endothelial Cells\u2014Focus on Endothelium-Derived Vasoactive Mediators","author":"F\u00e9l\u00e9tou","year":"2011"},{"key":"10.1016\/j.jphs.2024.11.002_bib34","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.RES.49.5.1152","article-title":"Sites of prostaglandin synthesis in the bovine heart and isolated bovine coronary microvessels","volume":"49","author":"Gerritsen","year":"1981","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2024.11.002_bib35","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00005344-199404000-00009","article-title":"Localization of endothelin immunoreactivity and demonstration of constrictory endothelin-A receptors in human coronary arteries and veins","volume":"23","author":"Saetrum","year":"1994","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib36","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1161\/01.HYP.0000018041.48432.B5","article-title":"Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels","volume":"39","author":"Guzik","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.jphs.2024.11.002_bib37","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/CIRCULATIONAHA.106.612325","article-title":"5-methyltetrahydrofolate rapidly improves endothelial function and decreases superoxide production in human vessels: effects on vascular tetrahydrobiopterin availability and endothelial nitric oxide synthase coupling","volume":"114","author":"Antoniades","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2024.11.002_bib38","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1161\/01.RES.0000269183.13937.e8","article-title":"Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB","volume":"100","author":"Donato","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.jphs.2024.11.002_bib39","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1172\/JCI28371","article-title":"Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels","volume":"116","author":"Stasch","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jphs.2024.11.002_bib40","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000371491","article-title":"Effects of peroxynitrite on relaxation through the NO\/sGC\/cGMP pathway in isolated rat iliac arteries","volume":"51","author":"Tawa","year":"2014","journal-title":"J Vasc Res"},{"key":"10.1016\/j.jphs.2024.11.002_bib41","first-page":"H383","article-title":"Redistribution of coronary microvascular resistance produced by dipyridamole","volume":"256","author":"Chilian","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/j.jphs.2024.11.002_bib42","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/clc.4960100910","article-title":"Attenuation of nitroglycerin-induced coronary hyperemic blood flow in patients with left anterior descending coronary collaterals","volume":"10","author":"Kern","year":"1987","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jphs.2024.11.002_bib43","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0167-5273(00)00285-0","article-title":"Differential coronary hemodynamics and left ventricular contractility in patients with syndrome X","volume":"75","author":"Chen","year":"2000","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jphs.2024.11.002_bib44","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/HYPERTENSIONAHA.106.083832","article-title":"Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure","volume":"49","author":"Boerrigter","year":"2007","journal-title":"Hypertension"},{"issue":"suppl 1","key":"10.1016\/j.jphs.2024.11.002_bib45","article-title":"Cardiovascular effects of the soluble guanylyl cyclase activator BAY 58\u20132667 in anesthetized dogs","volume":"7","author":"Hoffmann","year":"2007","journal-title":"BMC Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib46","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1177\/0091270008322906","article-title":"Pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in healthy male volunteers","volume":"48","author":"Frey","year":"2008","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jphs.2024.11.002_bib47","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1161\/CIRCULATIONAHA.108.800292","article-title":"Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure","volume":"119","author":"Lapp","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jphs.2024.11.002_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/eurheartj\/ehs196","article-title":"Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure","volume":"34","author":"Erdmann","year":"2013","journal-title":"Eur Heart J"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861324000720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861324000720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:50:04Z","timestamp":1734522604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861324000720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1347861324000720"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2024.11.002","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Different sensitivities of porcine coronary arteries and veins to BAY 60\u20132770, a soluble guanylate cyclase activator","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2024.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}